LBA55 WJOG @Be study: A phase II study of atezolizumab (atez) with bevacizumab (bev) for non-squamous (sq) non-small cell lung cancer (NSCLC) with high PD-L1 expressionT. Seto,K. Nosaki,M. Shimokawa, R. Toyozawa,S. Sugawara,H. Hayashi,H. Murakami,T. Kato,S. Niho,H. Saka,M. Oki,H. Yoshioka, I. Okamoto,H. Daga,K. Azuma,H. Tanaka,K. Nishino,M. Satouchi,N. Yamamoto, K. NakagawaAnnals of Oncology（2020）引用 11|浏览73暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
